Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
1.280
+0.030 (2.40%)
At close: Nov 4, 2024, 4:00 PM
1.290
+0.010 (0.78%)
After-hours: Nov 4, 2024, 6:07 PM EST
Protalix BioTherapeutics Employees
Protalix BioTherapeutics had 208 employees as of December 31, 2023. The number of employees increased by 11 or 5.58% compared to the previous year.
Employees
208
Change (1Y)
11
Growth (1Y)
5.58%
Revenue / Employee
$182,947
Profits / Employee
-$70,644
Market Cap
94.13M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
FONAR | 561 |
MDxHealth | 300 |
CASI Pharmaceuticals | 176 |
OptimizeRx | 136 |
BioAtla | 65 |
InflaRx | 62 |
Oncolytics Biotech | 29 |
Renovaro | 25 |
PLX News
- 10 days ago - Protalix BioTherapeutics to Present Phase I PRX-115 Data in Late-Breaking Poster at ACR Convergence 2024 - PRNewsWire
- 6 weeks ago - Kaskela Law LLC Announces Shareholder Investigation of Protalix BioTherapeutics, Inc. (NYSE: PLX) and Encourages Investors to Contact the Firm - Business Wire
- 7 weeks ago - Protalix BioTherapeutics to Present at the Life Sciences Investor Forum September 19, 2024 - GlobeNewsWire
- 2 months ago - Protalix BioTherapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - PRNewsWire
- 2 months ago - Protalix BioTherapeutics Announces Repayment of Outstanding Senior Secured Convertible Promissory Notes - PRNewsWire
- 2 months ago - Protalix BioTherapeutics, Inc. (PLX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Protalix BioTherapeutics Reports Second Quarter 2024 Financial and Business Results - PRNewsWire
- 3 months ago - Protalix BioTherapeutics to Announce Second Quarter 2024 Financial and Business Results on August 14, 2024 - PRNewsWire